Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia
- 作者Sergio Fazio; John R. Guyton; Adam B. Polis; Adeniyi J. Adewale; Joanne E. Tomassini; Nicholas W. Ryan; Andrew M. Tershakovec
- 卷第105卷
- 期第4期
- 印刷ISSN0002-9149
- 文件大小1029.58KB
- 发表时间2010
- DOI10.1016/j.amjcard.2009.10.001
- 页码487-494
同作者推荐
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual riskRobert S. Rosenson; Michael H. Davidson; Ray Pourfarzib · 2010
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analysis of controlled studiesEli M. Roth; Robert S. Rosenson; Peter H. Jones; Michael H. Davidson; Maureen T. Kelly; Carolyn M. Setze; Aditya Lele; Kamlesh Thakker · 2012